Plus   Neg

Kantaro Biosciences Receives CE Marking For SARS-CoV-2 IgG Antibody Test Kits

Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI (RENX.L,RNLX), and partner Bio-Techne Corp. (TECH), have received CE marking for COVID-SeroKlir and COVID-SeroIndex, Kantaro's quantitative SARS-CoV-2 IgG antibody test kits. COVID-SeroKlir is configured to be most useful in a clinical setting. COVID-SeroIndex configuration is anticipated to be used for research purposes or vaccine development. Both test kits are available immediately and can be used by any authorized clinical testing laboratory in the European Union.

Chuck Kummeth, Bio-Techne's CEO, said: "We are prepared to produce up to 10 million tests per month and ready to support any further rapid expansion."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration said that it will rapidly work toward finalization and issuance of an emergency use authorization of Johnson & Johnson's (JNJ) single-shot COVID-19 vaccine candidate. Billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) reported that its fourth-quarter net earnings attributable to shareholders rose 23 percent to $35.84 billion from last year's $29.16 billion, with earnings per share improving to $23,015 per Class A share from $17,909 per Class A share in the prior year. Walmart Inc. has launched a nationwide drive to boost COVID-19 vaccination rates by reaching out to more residents in vulnerable communities. The retail giant will organize a series of community events at 43 locations in 18 states to administer the COVID-19 vaccine. Walmart said it plans to continue these new events over the next several weeks as vaccine allocations allow.
Follow RTT